2025-522531-34-00SuspendedPhase 1
Methotrexate PK (in combination with Novobiocin) in RA patients
Source: EU CTIS (euclinicaltrials.eu) · Last updated 24 Apr 2026
- Status (registry)
- Suspended
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (estimated)
- First submitted
- 7 Jul 2025
- Start date
- 19 Aug 2025
- Lead sponsor
- Amplio Pharma B.V.
- Diseases
- Rheumatoid arthritis
- EU CT number
- 2025-522531-34-00
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre for Human Drug Research | Leiden | Netherlands | Suspended |
This page is information, not medical advice. Discuss any trial with your doctor.